Clinical Research Detail Title Of Study A clinical Trial to compare the effects and safety of linagliptin 2.5 mg twice daily dose vs linagliptin 5 mg once daily dose for 12 weeks with background therapy of metformin, in subjects who are not exposed to linagliptin or previously treated with other oral hypoglycemic drugs(after with holding the treatment for 4weeks) in patients with type 2 diabetes mellitus and insufficient blood glucose control Disease Condition Type 2 Diabetes Mellitus Phase of Trial Phase-2 Discipline Diabetology Start date of Trial 11/12/2009 Closing Date of Trial 11/12/2010 If you are a doctor interested in clinical research then upload your profile. Click here If you are a hospital interested in clinical research then upload your profile. Click here If you are a patient interested to know more about this clinical trial mail us at:   [email protected]